Transplant Diagnostic Market |with Key-Players Strategies | and Industry Updates with Forecast

SDKI Inc. published a new research report on "Transplant Diagnostic Market-World Forecast 2023" on April 21, 2021. The report provides a complete assessment of the market and its growth prospects, along with new business opportunities in the industry. It also includes market size and annual growth during the 2018-2023 forecast period.

Report sample URL
https://www.sdki.jp/sample-request-109970

The global transplant diagnostics market is estimated to reach US $ 4.91 billion by 2023 from US $ 3.44 billion in 2018 and is projected to grow at a CAGR of 7.4%. Increased transplant procedures, technological advances in the field of transplant diagnosis, increased public and private funding for targeted research activities, and an increasing burden of infectious diseases are several factors contributing to the growth of this market.

Market Segment

Transplant Diagnostics Market is by technology (molecular assay (PCR-based assay, sequencing-based assay technology) and non-molecular assay), product (device, reagent, software), application (HLA, blood profile, pathogen). It is divided by detection), type (heart, kidney, liver, stem cells), end user (hospital) and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The Molecular Assay Technology segment is expected to be the fastest growing segment during the forecast period.

Based on the technology, the transplant diagnostic market is divided into molecular (PCR-based assay and sequence-based assay technology) and non-molecular assays. The molecular assay technology segment is expected to grow at a maximum CAGR during the forecast period. This growth may be due to the technical advantages of molecular assays such as short turnaround times, high procedural efficiency, multiple sample studies, and real-time sample analysis.

Area overview

The transplant diagnostic market is further subdivided based on region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, United Kingdom, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions. Of these regions, the Asia Pacific region is expected to occupy significant market share during the forecast period. Growth in the region has led to increased adoption of state-of-the-art diagnostic techniques among healthcare professionals, a surge in the elderly population (especially Japan and China), and universal government health insurance in Japan (transplantation and related). It is presumed to be due to (including diagnostic procedures).

Report sample URL
https://www.sdki.jp/sample-request-109970

Analysis of primary supply interviews: by company type, by designation, and by region:
- By company type-Tier 1 – 25%, Tier 2 – 30%, Tier 3 – 45%
- By designation – executive level – 26%, board level – 30%, others – 44%
- By Region – North America – 34%, Europe – 26%, APAC – 23%, ROW – 17%

Details of the survey report
https://www.sdki.jp/reports/transplant-diagnostics-market/109970

Key Players in the Market The key players

in the transplant diagnostic market are Thermo Fisher Scientific Inc. (USA), Bio-Rad Laboratories, Inc. (USA), F.Hoffman-LaRoche Ltd. (Switzerland), QIAGEN NV. (Netherlands), Immucor, Inc. (USA), etc. The study includes a detailed competitive analysis of these major companies in the transplant diagnostics market, corporate profiles, recent developments, and key market strategies.

Contact Us:

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.